Joshua Silverman

Joshua Silverman

Directeur Général chez PHARMACYTE BIOTECH, INC.

Fortune : 2 M $ au 30/06/2026

55 ans
Health Technology
Finance
Consumer Services

Profil

Joshua Nathaniel Silverman is the founder of Iroquois Capital LP, founded in 2002, serving as Chief Executive Officer.
Mr. Silverman is the founder of Iroquois Capital Management LLC, founded in 2003, serving as Co-Chief Investment Officer & Managing Member from 2003 to 2016.
Mr. Silverman is the founder of Parkfield Funding LLC, founded in 2016, serving as Managing Member.
Current jobs include Chairman, President & Chief Executive Officer at PharmaCyte Biotech, Inc. since 2022; Executive Chairman & Chief Executive Officer at Fabric.
AI, Inc. since 2020; Chairman at Neurotrope, Inc. since 2016; Executive Chairman at TAO Synergies, Inc. since 2016; Executive Chairman at Q since 2018; Executive Chairman at Petros Pharmaceuticals, Inc. since 2020; Director at Crellin Capital LLC; and Director at Taplmmune , Inc. Former jobs include Chief Executive Officer & Director at AYRO, Inc.; Chairman at DropCar Operating Co., Inc.; Chairman at MIRA Pharmaceuticals, Inc.; Chairman at Maritime Resources Corp.; Director at Alanco Technologies, Inc. in 2016; Independent Director at National Holdings Corp.
from 2014 to 2016; Director at WPCS International, Inc.; Independent Director at Marker Therapeutics, Inc. from 2016 to 2018; Lead Independent Director at Akers Biosciences, Inc. from 2018 to 2020; Independent Director at MGT Capital Investments, Inc. from 2014 to 2016; Director at Atrinsic, Inc.; Director at Joele Frank, Wilkinson Brimmer Katcher; Director at JNS Holdings Corp.; Independent Non-Executive Director at Protagenic Therapeutics, Inc. from 2016 to 2022; Independent Director at Femasys, Inc. from 2023 to 2026; and Co-Chief Investment Officer at Vertical Ventures LLC from 2000 to 2003.
Education includes an undergraduate degree from Lehigh University, conferred in 1992.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
13/04/2026 262 191 ( 3,34% ) 1 M $ 30/06/2026
18/05/2026 86 681 ( 1,16% ) 323 320 $ 30/06/2026
01/02/2026 366 250 ( 3,41% ) 282 013 $ 30/06/2026
22/04/2026 3 091 ( 0,06% ) 11 406 $ 30/06/2026
05/06/2026 450 ( 0% ) 2 $ 30/06/2026

Postes actifs de Joshua Silverman

SociétésPosteDébut
NEUROTROPE, INC. Président 04/08/2016
FABRIC.AI, INC. Directeur Général -
PETROS PHARMACEUTICALS Président -
SYNAPTOGENIX, INC. Président 04/08/2016
Q/C TECHNOLOGIES, INC. Président 01/09/2025
PHARMACYTE BIOTECH, INC. Directeur Général 06/10/2022
Taplmmune, Inc.
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Fondateur 01/08/2016
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░

Anciens postes connus de Joshua Silverman

SociétésPosteFin
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Joshua Silverman

Formation de Joshua Silverman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

57

Relations au 1er degré

28

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées28

Industrial Services

Finance

Consumer Services

Health Technology

Electronic Technology

Non-Energy Minerals

Health Technology

Finance

Health Technology

Finance

Consumer Services

Technology Services

Commercial Services

Finance

Health Technology

Commercial Services

Industrial Services

Technology Services

Health Technology

Finance

Finance

Consumer Services

Producer Manufacturing

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Taplmmune, Inc.

  1. Bourse
  2. Insiders
  3. Joshua Silverman